Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

Recent Guideline Updates on Frontline Treatment for Chronic Lymphocytic Leukemia

Dr. Fenske discusses omitting ASCT in Mantle Cell Lymphoma after first CR.

Dr. van Meerten discusses Brexu-Cel efficacy and safety in BTK inhibitor–naive R/R MCL.

‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.